Learning Objectives:

1.  Gain new insights into myelodysplastic syndromes (MDS) and sickle cell disease (SCD)

2.  Delineate molecular mechanisms underlying epigenetic regulation of transcription

3.  To understand the benefits of non-cytotoxic drugs for treatment of MDS and SCD

Session date: 
02/14/2022 - 12:00pm to 1:00pm CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Amittha Wickrema